Abstract:Current studies have indicated that donepezil as a cholinesterase inhibitor can attenuate morphine-induced tolerance. The present study aimed to evaluate the possible role of N-methyl-d-aspartate receptors (NMDARs), protein kinase C (PKC) and CaM-dependent kinase II (CaMKII) pathways in this effect. Female Wistar rats received daily morphine (10 mg/kg, i.p.) alone or in combination with donepezil (1.5 or 2 mg/kg, gavaged) for 14 days. The analgesic effect was assessed by Von-frey, hotplate and tail flick test. On the 15th day, the periaqueductal gray (PAG) and lumbar spinal cord of rats were dissected. Then, protein levels of NMDAR-NR1, NR2B, PKCγ and CaMKIIα were tested using Western blot method. The results showed that morphine tolerance was seen after 8–10 days of injection compared with control group, while daily co-administration of donepezil with morphine prolonged the occurrence of analgesic tolerance. Western blot showed that morphine significantly increased NR1, PKCγ and CaMKIIα expressions in PAG, and significantly increased PKCγ and CaMKIIα in spinal cord. In contrast, donepezil downregulated NR1 and PKCγ in PAG, and downregulated PKCγ and CaMKIIα in spinal cord. Moreover, donepezil alone activates NR1 and NR2B in spinal cord, which needs to be further studied. Thus, the present results suggest that the attenuation effects of donepezil on morphine tolerance are possibly mediated by preventing morphine-induced upregulations in NR1, PKCγ and CaMKIIα expressions.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism by which Donepezil prevents morphine tolerance by regulating the expressions of N - methyl - D - aspartic acid receptor (NMDAR), protein kinase C (PKC) and calmodulin - dependent kinase II (CaMKII). Specifically, the study aims to evaluate the roles of these pathways in Donepezil - mediated attenuation of morphine tolerance. ### Research Background Opioid drugs (such as morphine) are one of the main drugs for treating cancer pain. However, long - term use can lead to a series of side effects, such as drowsiness, respiratory depression and gastrointestinal reactions. Most importantly, there are problems of tolerance and physical dependence. These problems lead to a decline in the analgesic effect of opioid drugs and an increase in patients' demand for drugs. Therefore, it is crucial to understand the mechanisms of long - term use of opioid drugs and explore effective interventions. ### Research Objectives 1. **Evaluate the effect of Donepezil on morphine tolerance**: Investigate whether Donepezil can delay or prevent the occurrence of morphine tolerance by regulating the expressions of NMDAR, PKC and CaMKII. 2. **Explore the specific molecular mechanisms**: Clarify how Donepezil affects the expressions of key proteins in these pathways, especially NMDAR - NR1, NR2B, PKCγ and CaMKII α. ### Experimental Design - **Animal model**: Female Wistar rats were used and divided into multiple experimental groups, including the control group (treated with normal saline), the morphine group, the Donepezil group and the morphine + Donepezil combination group. - **Behavioral tests**: Von - Frey, hot - plate and tail - flick tests were used to evaluate the changes in mechanical sensitivity and thermal pain threshold in rats. - **Western Blot analysis**: Detect the protein expression levels of NMDAR - NR1, NR2B, PKCγ and CaMKII α in the periaqueductal gray (PAG) of the hypothalamus and the lumbar spinal cord. ### Main Findings - **Morphine tolerance**: Rats treated with morphine alone showed obvious analgesic tolerance after 8 - 10 days. - **Effect of Donepezil**: - The combined use of Donepezil and morphine significantly prolonged the delay time of tolerance occurrence. - Western Blot results showed that morphine significantly increased the expressions of NR1, PKCγ and CaMKII α in PAG, while Donepezil down - regulated the expressions of these proteins. - In the spinal cord, morphine significantly increased the expressions of PKCγ and CaMKII α, and Donepezil also down - regulated the expressions of these proteins. ### Conclusion The study shows that Donepezil can effectively delay or prevent the occurrence of morphine tolerance by regulating the expressions of NMDAR - NR1, PKCγ and CaMKII α. This finding provides a theoretical basis for developing new strategies to reduce the tolerance and dependence of opioid drugs. ### Formula Representation When calculating the maximum possible effect percentage (%MPE), the formula is as follows: \[ \%MPE=\left(\frac{\text{latency after administration}-\text{baseline latency}}{\text{cut - off time}-\text{baseline latency}}\right)\times100\% \] where the latency refers to the time from the start of stimulation to the response of the rat, the baseline latency is the average latency measured before administration, and the cut - off time is the maximum latency set to avoid tissue damage.

Donepezil prevents morphine tolerance by regulating N-methyl-d-aspartate receptor, protein kinase C and CaM-dependent kinase II expression in rats

Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: The role of cortical N-methyl-D-aspartate receptors

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Role of the spinal NMDA receptor NR2B subunit in inhibition of morphine tolerance by agmatine

Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence

Role of P2X7 Receptor-Mediated IL-18/IL-18R Signaling in Morphine Tolerance: Multiple Glial-Neuronal Dialogues in the Rat Spinal Cord.

Chronic, but Not Acute Morphine Treatment, Up-regulates α-Ca 2+ /calmodulin Dependent Protein Kinase II Gene Expression in Rat Brain

miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats.

Dysregulation of Vesicular Glutamate Transporter VGluT2 Via BDNF/TrkB Pathway Contributes to Morphine Tolerance in Mice

Upregulation of μ-Opioid Receptor in the Rat Spinal Cord Contributes to the α2-Adrenoceptor Agonist Dexmedetomidine-Induced Attenuation of Chronic Morphine Tolerance in Cancer Pain

Amiloride Alleviates Morphine Tolerance by Suppressing ASIC3-dependent Neuroinflammation in the Spinal Cord.

Effect of Heat Shock Protein 70 Modulators on the Development of Morphine Analgesic Tolerance in Rats

Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors

Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor Stimulation

Improvement of Morphine-Mediated Analgesia by Inhibition of Β-Arrestin 2 Expression in Mice Periaqueductal Gray Matter

Spinal heat shock protein 27 participates in PDGFRβ‐mediated morphine tolerance through PI3K/Akt and p38 MAPK signalling pathways

The α 1 adrenoceptor antagonist prazosin potentiates morphine induced conditioned place preference in rats

Involvement of Protein Kinase C in Morphine Tolerance at Spinal Levels of Rats

miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats

Molecular Chaperone Heat Shock Protein 70 Inhibitors Suppress Conditioned Place Preference Induced by Morphine Exposure in Male Rats.

Influence of N-methyl-D-aspartic acid receptor on the plasticity of ucleus accumbens synapses in chronic morphine dependent rats